To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MEGF8TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
186 supporting clones for gene MEGF8 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW298432   MEGF8.a 1 to 247 253 to -5   tiling clone,   253/302
(83 %)
1 diff
(99.7 %id)
CN282982 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MEGF8.a 228 to 892 1 to 665       665/665
(100 %)
1 diff
(99.9 %id)
AB011541 brain MEGF8.a 243 to 6470 1 to 6228   available from KIAA,   6228/6228
(100 %)
0 diff
(100 %id)
BC153880 Clones donated by Kazusa DNA Research Inst. MEGF8.a 243 to 10225 1 to 9983 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 9983/9983
(100 %)
0 diff
(100 %id)
NM_001410.2   MEGF8.a 243 to 11208 1 to 10966 exact RefSeq,   10966/10966
(100 %)
0 diff
(100 %id)
BU931033 ovary, teratocarcinoma, cell line MEGF8.a 323 to 1064 1 to 744       744/913
(81 %)
8 diff
(99.2 %id)
BF884008 lung_tumor MEGF8.a 1813 to 1964 23 to 169       147/169
(86 %)
6 diff
(96.5 %id)
CV354948 lung_tumor MEGF8.a 2192 to 2306 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
CV354949 lung_tumor MEGF8.a 2324 to 2450 1 to 128       128/128
(100 %)
3 diff
(97.7 %id)
BF923583 nervous_tumor MEGF8.a 2974 to 3216 241 to 1     Submitted on the opposite strand 241/264
(91 %)
4 diff
(98.5 %id)
BQ325528 colon_ins MEGF8.a 4678 to 4821 21 to 160       140/170
(82 %)
11 diff
(93.6 %id)
BF944854 nervous_normal MEGF8.a 4680 to 4821 23 to 164       142/174
(81 %)
7 diff
(96.0 %id)
CN281629 embryonic stem cells, DMSO-treated H9 cellline MEGF8.a 4990 to 5717 1 to 728       728/728
(100 %)
1 diff
(99.9 %id)
BF842027 head_neck MEGF8.a 5229 to 5773 553 to 1     Submitted on the opposite strand 553/555
(99 %)
27 diff
(95.2 %id)
BE840148 prostate_normal MEGF8.a 5414 to 5722 321 to 16       309/321
(96 %)
4 diff
(98.8 %id)
BE840226 prostate_normal MEGF8.a 5414 to 5687 322 to 49       274/322
(85 %)
0 diff
(100 %id)
BQ056122 lymph, lymphoma, cell line MEGF8.a 6079 to 6714 1 to 636       636/977
(65 %)
20 diff
(98.0 %id)
BQ054453 lymph, lymphoma, cell line MEGF8.a 6081 to 6892 1 to 824       824/1069
(77 %)
27 diff
(97.5 %id)
BQ056482 lymph, lymphoma, cell line MEGF8.a 6081 to 6735 1 to 656       656/1148
(57 %)
5 diff
(99.6 %id)
BQ059804 lymph, lymphoma, cell line MEGF8.a 6081 to 6912 1 to 838       838/1004
(83 %)
16 diff
(98.5 %id)
BQ060741 lymph, lymphoma, cell line MEGF8.a 6081 to 6912 1 to 839       839/1008
(83 %)
14 diff
(98.7 %id)
AW899314 nervous_normal MEGF8.a 6642 to 6895 257 to 4       254/264
(96 %)
0 diff
(100 %id)
CN281631 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MEGF8.a 6738 to 6887 1 to 150       150/150
(100 %)
0 diff
(100 %id)
BE018555 cervix MEGF8.a 6766 to 7114 1 to 349       349/349
(100 %)
3 diff
(99.2 %id)
CN281626 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MEGF8.a 6833 to 7105 1 to 273       273/273
(100 %)
0 diff
(100 %id)
BU846445 ovary, teratocarcinoma, cell line MEGF8.a 6850 to 7592 1 to 753       751/977
(76 %)
21 diff
(97.9 %id)
CV572933 cornea, eye MEGF8.a 7180 to 7768 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BG106784 lymph, lymphoma, cell line MEGF8.a 7434 to 7510 1 to 76       76/76
(100 %)
0 diff
(100 %id)
CN281628 embryonic stem cells, cell lines H1, H7, andH9 MEGF8.a 7745 to 8203 1 to 459       459/459
(100 %)
0 diff
(100 %id)
BE880306 large cell carcinoma, undifferentiated, lung MEGF8.a 7897 to 7963 1 to 66       66/66
(100 %)
1 diff
(98.5 %id)
BQ929439 leiomyosarcoma, uterus MEGF8.a 7991 to 8894 1 to 911       911/917
(99 %)
25 diff
(97.3 %id)
BX431580 brain, fetal brain MEGF8.a 8023 to 8856 1 to 843       843/1042
(80 %)
62 diff
(94.1 %id)
BX431579 brain, fetal brain MEGF8.a 8027 to 8670 1 to 641       641/980
(65 %)
19 diff
(98.1 %id)
BG287691 bladder, transitional cell papilloma, cell line MEGF8.a 8087 to 8807 1 to 718       718/748
(95 %)
14 diff
(98.2 %id)
CN281632 embryonic stem cells, cell lines H1, H7, andH9 MEGF8.a 8132 to 8552 1 to 421       421/421
(100 %)
1 diff
(99.8 %id)
TI_149296467   MEGF8.a 8269 to 9058 925 to 144       782/929
(84 %)
0 diff
(100 %id)
BG420143 Kidney, renal cell adenocarcinoma MEGF8.a 8327 to 9082 1 to 747       747/751
(99 %)
17 diff
(97.8 %id)
BU684410 lung, Primary Lung Cystic Fibrosis EpithelialCells MEGF8.a 8475 to 9058 664 to 81   AAA   584/646
(90 %)
0 diff
(100 %id)
BF344374 brain, glioblastoma with EGFR amplification MEGF8.a 8765 to 9513 1 to 749       749/807
(92 %)
17 diff
(97.9 %id)
BG760846 melanotic melanoma, high MDR (cell line), skin MEGF8.a 8847 to 9542 1 to 701       701/701
(100 %)
7 diff
(99.1 %id)
BG769603 melanotic melanoma, high MDR (cell line), skin MEGF8.a 8847 to 9614 1 to 770       770/772
(99 %)
9 diff
(98.9 %id)
CR984532 T-Lymphocytes MEGF8.a 8893 to 9343 1 to 451       451/453
(99 %)
2 diff
(99.6 %id)
BQ723273 sympathetic trunk MEGF8.a 8920 to 9597 1 to 694       694/872
(79 %)
34 diff
(96.2 %id)
AA311518   MEGF8.a 8970 to 9287 1 to 318       318/318
(100 %)
0 diff
(100 %id)
BQ638780 eye, retina MEGF8.a 9157 to 9777 1 to 621       621/621
(100 %)
5 diff
(99.2 %id)
BF204431 muscle, rhabdomyosarcoma MEGF8.a 9160 to 9751 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BU554097 ovary, teratocarcinoma, cell line MEGF8.a 9169 to 10018 1 to 854       854/857
(99 %)
9 diff
(99.0 %id)
BE906700 epithelioid carcinoma, Pancreas MEGF8.a 9172 to 9869 1 to 693       693/870
(79 %)
15 diff
(98.3 %id)
BQ061459 lymph, lymphoma, cell line MEGF8.a 9172 to 10078 1 to 920       920/1077
(85 %)
26 diff
(97.6 %id)
BQ642973 lymph, lymphoma, cell line MEGF8.a 9172 to 9987 1 to 820       820/957
(85 %)
16 diff
(98.4 %id)
TI_154030143   MEGF8.a 9353 to 10225 924 to 65   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 860/923
(93 %)
12 diff
(98.7 %id)
BF957226 nervous_normal MEGF8.a 9426 to 9721 297 to 4       294/314
(93 %)
0 diff
(100 %id)
CA442385 Fibrosarcoma MEGF8.a 9468 to 10225 774 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 756/756
(100 %)
2 diff
(99.8 %id)
BM048588 carcinoma, cell line, Prostate MEGF8.a 9486 to 10247 1 to 774       774/847
(91 %)
17 diff
(98.0 %id)
BM049334 carcinoma, cell line, Prostate MEGF8.a 9486 to 10048 1 to 563       563/565
(99 %)
2 diff
(99.7 %id)
BM049130 carcinoma, cell line, Prostate MEGF8.a 9486 to 10220 1 to 746       746/749
(99 %)
29 diff
(96.2 %id)
AA374018 lung MEGF8.a 9487 to 9715 1 to 230       230/230
(100 %)
1 diff
(99.6 %id)
CA442957 Fibrosarcoma MEGF8.a 9494 to 10225 750 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 732/732
(100 %)
0 diff
(100 %id)
CX759169 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass MEGF8.a 9502 to 10288 1 to 782     Submitted on the opposite strand 782/782
(100 %)
6 diff
(99.3 %id)
BM688425 eye, human retina MEGF8.a 9510 to 9993 1 to 484       484/484
(100 %)
5 diff
(99.0 %id)
BI054390 placenta_normal MEGF8.a 9524 to 9775 250 to 1       250/250
(100 %)
5 diff
(98.0 %id)
CX872706 embryonic stem MEGF8.a 9528 to 10269 1 to 744       744/744
(100 %)
4 diff
(99.5 %id)
AV751780 Pituitary MEGF8.a 9539 to 10205 1 to 663       663/676
(98 %)
8 diff
(98.9 %id)
AW500620 lymph MEGF8.a 9550 to 9933 8 to 391       384/391
(98 %)
6 diff
(98.5 %id)
TI_154154857   MEGF8.a 9550 to 10154 80 to 681       602/667
(90 %)
35 diff
(94.8 %id)
CV813967 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass MEGF8.a 9576 to 10414 1 to 838       838/889
(94 %)
15 diff
(98.4 %id)
CX783655 human embryonic stem cells MEGF8.a 9578 to 10367 1 to 790       790/790
(100 %)
0 diff
(100 %id)
BF922571 nervous_tumor MEGF8.a 9633 to 9900 7 to 274       268/279
(96 %)
6 diff
(97.9 %id)
BQ344609 nervous_tumor MEGF8.a 9640 to 9900 22 to 283       262/288
(90 %)
13 diff
(95.5 %id)
CN281627 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MEGF8.a 9692 to 10222 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
BG059632 brain, glioblastoma without EGFR amplification MEGF8.a 9761 to 10228 468 to 1       468/468
(100 %)
2 diff
(99.6 %id)
BP387611 pancreatic islet MEGF8.a 9773 to 10229 1 to 457     Submitted on the opposite strand 457/457
(100 %)
2 diff
(99.6 %id)
AA729974 pooled germ cell tumors MEGF8.a 9774 to 10225 450 to 1       450/450
(100 %)
3 diff
(99.4 %id)
AI050071   MEGF8.a 9820 to 10235 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AI588882 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MEGF8.a 9826 to 10234 409 to 1       409/409
(100 %)
3 diff
(99.3 %id)
AW162961 brain, frontal lobe MEGF8.a 9833 to 10232 400 to 1       400/400
(100 %)
1 diff
(99.8 %id)
DB279511 uterus MEGF8.a 9838 to 10348 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
AA523233 metastatic prostate bone lesion MEGF8.a 9849 to 10229 380 to 1       380/387
(98 %)
1 diff
(99.8 %id)
AI536592 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MEGF8.a 9857 to 10227 371 to 1       371/371
(100 %)
0 diff
(100 %id)
TI_149278632   MEGF8.a 9899 to 10636 60 to 789     Submitted on the opposite strand 730/791
(92 %)
17 diff
(97.9 %id)
TI_149304210   MEGF8.a 9899 to 10794 59 to 943     Submitted on the opposite strand 885/1055
(83 %)
25 diff
(97.7 %id)
TI_149304246   MEGF8.a 9899 to 10863 54 to 1005     Submitted on the opposite strand 952/1084
(87 %)
31 diff
(97.2 %id)
CB851130 lung, Primary Lung Epithelial Cells MEGF8.a 9899 to 10663 12 to 776     Submitted on the opposite strand 765/776
(98 %)
6 diff
(99.3 %id)
CB854154 lung, Primary Lung Epithelial Cells MEGF8.a 9899 to 10575 12 to 680     Submitted on the opposite strand 669/680
(98 %)
6 diff
(99.2 %id)
CB851131 lung, Primary Lung Epithelial Cells MEGF8.a 9899 to 10632 12 to 746     Submitted on the opposite strand 735/746
(98 %)
6 diff
(99.2 %id)
TI_149278668   MEGF8.a 9909 to 10636 1 to 730     Submitted on the opposite strand 730/730
(100 %)
23 diff
(96.9 %id)
BM686562 eye, optic nerve MEGF8.a 9926 to 10579 9 to 662     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 654/662
(98 %)
6 diff
(99.1 %id)
CD702368 normal nasopharynx MEGF8.a 10020 to 10346 34 to 363       330/363
(90 %)
8 diff
(97.8 %id)
CX753123 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass MEGF8.a 10045 to 10804 1 to 758   tiling clone, Submitted on the opposite strand 758/766
(98 %)
8 diff
(99.0 %id)
EB388716 eye, optic nerve MEGF8.a 10090 to 10906 1 to 817       817/817
(100 %)
1 diff
(99.9 %id)
EL954487 eyeball MEGF8.a 10113 to 10517 1 to 402       402/402
(100 %)
8 diff
(98.1 %id)
AA973844 pooled germ cell tumors MEGF8.a 10148 to 10225 78 to 1       298/406
(73 %)
10 diff
(97.6 %id)
AW898385 nervous_normal MEGF8.a 10267 to 10581 13 to 325       313/327
(95 %)
5 diff
(98.5 %id)
TI_149311353   MEGF8.a 10281 to 11206 997 to 83   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 915/995
(91 %)
27 diff
(97.3 %id)
TI_154026890   MEGF8.a 10351 to 11200 930 to 81   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 850/1107
(76 %)
35 diff
(96.9 %id)
CB122799 Liver MEGF8.a 10366 to 10979 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BM711470 eye, fetal eyes MEGF8.a 10391 to 10782 1 to 392     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 392/392
(100 %)
5 diff
(98.8 %id)
CB163431 Liver MEGF8.a 10403 to 10978 1 to 576       576/576
(100 %)
0 diff
(100 %id)
TI_149308743   MEGF8.a 10409 to 11200 866 to 84   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 783/963
(81 %)
9 diff
(99.1 %id)
AK026018   MEGF8.a 10416 to 11200 1 to 785   available from FLJ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 785/785
(100 %)
0 diff
(100 %id)
BU689397 lung MEGF8.a 10425 to 11206 798 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 780/780
(100 %)
8 diff
(99.0 %id)
BG946306 bladder_tumor MEGF8.a 10434 to 10690 1 to 260       260/260
(100 %)
15 diff
(94.3 %id)
TI_149284337   MEGF8.a 10436 to 11206 847 to 81       767/882
(86 %)
0 diff
(100 %id)
CB115588 Liver MEGF8.a 10456 to 10979 1 to 524       524/524
(100 %)
0 diff
(100 %id)
TI_149312211   MEGF8.a 10461 to 11181 865 to 150   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 716/868
(82 %)
0 diff
(100 %id)
BQ447363 Knee, Osteoarthritic Cartilage MEGF8.a 10468 to 11200 750 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 732/736
(99 %)
3 diff
(99.6 %id)
DN991563 brain, whole brain MEGF8.a 10477 to 11039 7 to 569       563/569
(98 %)
0 diff
(100 %id)
TI_149294032   MEGF8.a 10494 to 11200 790 to 86   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 705/705
(100 %)
2 diff
(99.8 %id)
BQ576282 Chondrosarcoma Grade II, Left Pelvis MEGF8.a 10494 to 11200 724 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 706/706
(100 %)
3 diff
(99.6 %id)
BF926878 nervous_tumor MEGF8.a 10500 to 10843 1 to 344       344/344
(100 %)
0 diff
(100 %id)
BU680499 lung MEGF8.a 10514 to 11206 711 to 19       693/713
(97 %)
0 diff
(100 %id)
BM984953 lung MEGF8.a 10516 to 11200 702 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 684/684
(100 %)
1 diff
(99.9 %id)
BU622209 Cell Line, Chondrosarcoma MEGF8.a 10520 to 11200 699 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 681/681
(100 %)
1 diff
(99.9 %id)
BU687203 lung MEGF8.a 10548 to 11200 670 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 652/652
(100 %)
2 diff
(99.7 %id)
BX412791 brain, fetal brain MEGF8.a 10559 to 11191 636 to 5       632/880
(71 %)
0 diff
(100 %id)
CA440378 Chondrosarcoma, Left Pubic Bone MEGF8.a 10570 to 11200 648 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 630/630
(100 %)
6 diff
(99.1 %id)
BF311166 brain, neuroblastoma MEGF8.a 10576 to 11170 1 to 597       597/929
(64 %)
7 diff
(99.3 %id)
BI196855 brain, neuroblastoma MEGF8.a 10576 to 11165 1 to 588       588/588
(100 %)
12 diff
(98.0 %id)
BI196039 brain, neuroblastoma MEGF8.a 10576 to 11164 1 to 590       590/590
(100 %)
6 diff
(99.0 %id)
TI_154134776   MEGF8.a 10618 to 11216 704 to 96   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 609/1129
(53 %)
59 diff
(94.8 %id)
BF847778 lung_normal MEGF8.a 10630 to 10972 350 to 5     Submitted on the opposite strand 346/350
(98 %)
0 diff
(100 %id)
DB484524 hypothalamus MEGF8.a 10635 to 11063 433 to 6     Submitted on the opposite strand 428/433
(98 %)
0 diff
(100 %id)
TI_151742411   MEGF8.a 10639 to 11200 706 to 137   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 570/1018
(55 %)
35 diff
(96.6 %id)
CA426997 Bone, Subchondral Bone MEGF8.a 10641 to 11200 578 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 560/560
(100 %)
13 diff
(97.7 %id)
W22362 eye, retina MEGF8.a 10653 to 11172 526 to 5       522/626
(83 %)
0 diff
(100 %id)
TI_154137225   MEGF8.a 10675 to 11216 640 to 101   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 540/545
(99 %)
3 diff
(99.5 %id)
CA425448 Bone, Subchondral Bone MEGF8.a 10676 to 11200 543 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 525/525
(100 %)
3 diff
(99.5 %id)
BF062538 colon, colon tumor, RER+ MEGF8.a 10683 to 11206 525 to 2       524/525
(99 %)
0 diff
(100 %id)
AI291205 carcinoid, lung MEGF8.a 10692 to 11200 509 to 1       509/509
(100 %)
0 diff
(100 %id)
R97175 liver and spleen MEGF8.a 10702 to 11008 1 to 318   fully sequenced,   318/318
(100 %)
8 diff
(97.5 %id)
AI378645 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MEGF8.a 10707 to 11199 493 to 1       493/493
(100 %)
0 diff
(100 %id)
BI033223 nervous_normal MEGF8.a 10708 to 11025 12 to 325       314/335
(93 %)
8 diff
(97.7 %id)
AW269914 pooled MEGF8.a 10730 to 11196 466 to 1       466/466
(100 %)
3 diff
(99.4 %id)
AI268384 carcinoid, lung MEGF8.a 10732 to 11206 476 to 2       475/476
(99 %)
0 diff
(100 %id)
BE219156 carcinoid, lung MEGF8.a 10738 to 11206 470 to 2       469/470
(99 %)
0 diff
(100 %id)
AW903992 nervous_normal MEGF8.a 10754 to 11128 398 to 23       376/398
(94 %)
0 diff
(100 %id)
AW005537 anaplastic oligodendroglioma, brain MEGF8.a 10755 to 11200 457 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 445/445
(100 %)
12 diff
(97.4 %id)
AI609273 normal gingiva (cell line from primarykeratinocytes) MEGF8.a 10767 to 11200 458 to 26   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 433/433
(100 %)
12 diff
(97.3 %id)
BU734820 eye, lens MEGF8.a 10773 to 11200 445 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 427/427
(100 %)
6 diff
(98.6 %id)
BF433919 carcinoid, lung MEGF8.a 10791 to 11204 418 to 5       414/418
(99 %)
0 diff
(100 %id)
H95648 liver and spleen MEGF8.a 10792 to 11204 427 to 5       423/433
(97 %)
0 diff
(100 %id)
TI_891527799   MEGF8.a 10802 to 11206 463 to 59     Submitted on the opposite strand 405/1223
(33 %)
0 diff
(100 %id)
TI_891527801   MEGF8.a 10802 to 11206 463 to 59     Submitted on the opposite strand 405/1248
(32 %)
0 diff
(100 %id)
TI_891527803   MEGF8.a 10802 to 11206 56 to 460     Submitted on the opposite strand 405/1249
(32 %)
3 diff
(99.8 %id)
TI_891527805   MEGF8.a 10802 to 11206 56 to 460     Submitted on the opposite strand 405/1213
(33 %)
3 diff
(99.8 %id)
TI_891529593   MEGF8.a 10802 to 11206 131 to 535     Submitted on the opposite strand 405/1251
(32 %)
3 diff
(99.8 %id)
BC093649 Lung and heart, PCR rescued clones MEGF8.a 10806 to 11206 1 to 401       401/406
(98 %)
1 diff
(99.8 %id)
BC111942 Lung and heart, PCR rescued clones MEGF8.a 10806 to 11206 1 to 401       401/406
(98 %)
1 diff
(99.8 %id)
AA716186 heart MEGF8.a 10811 to 11206 394 to 1       394/394
(100 %)
4 diff
(99.0 %id)
AI589130 brain, glioblastoma (pooled) MEGF8.a 10812 to 11200 388 to 1       388/388
(100 %)
9 diff
(97.7 %id)
AW294036   MEGF8.a 10814 to 11200 403 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 386/386
(100 %)
2 diff
(99.5 %id)
BF055979 pooled MEGF8.a 10820 to 11203 384 to 1       384/384
(100 %)
3 diff
(99.3 %id)
BM670720 eye, fetal eyes MEGF8.a 10824 to 11200 395 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 377/377
(100 %)
1 diff
(99.8 %id)
AF497566   MEGF8.a 10832 to 11173 1 to 342       342/342
(100 %)
0 diff
(100 %id)
AI091172 pooled MEGF8.a 10845 to 11200 381 to 27   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 355/357
(99 %)
23 diff
(93.6 %id)
T58691 placenta MEGF8.a 10847 to 11208 1 to 364       364/368
(98 %)
7 diff
(98.1 %id)
BF742265 breast MEGF8.a 10849 to 11069 1 to 218       218/230
(94 %)
7 diff
(97.0 %id)
AI091500 pooled MEGF8.a 10850 to 11202 353 to 1       353/353
(100 %)
9 diff
(97.5 %id)
AI452819 pooled MEGF8.a 10850 to 11202 353 to 1       353/353
(100 %)
0 diff
(100 %id)
AI436324 pooled MEGF8.a 10851 to 11202 352 to 1       352/352
(100 %)
0 diff
(100 %id)
AI383473 pooled MEGF8.a 10896 to 11200 330 to 27   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 304/304
(100 %)
20 diff
(93.5 %id)
AI566091 Kidney MEGF8.a 10903 to 11206 320 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 304/304
(100 %)
1 diff
(99.7 %id)
BF592011 Kidney MEGF8.a 10926 to 11200 294 to 20   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 275/275
(100 %)
2 diff
(99.3 %id)
AA554194 breast MEGF8.a 10935 to 11200 277 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 265/265
(100 %)
1 diff
(99.7 %id)
AI969767 pooled germ cell tumors MEGF8.a 10949 to 11200 278 to 28   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 251/251
(100 %)
20 diff
(92.1 %id)
R97176 liver and spleen MEGF8.a 10978 to 11204 240 to 1   fully sequenced,   240/240
(100 %)
2 diff
(99.2 %id)
BU727944 eye, optic nerve MEGF8.a 10987 to 11207 238 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 220/220
(100 %)
4 diff
(98.2 %id)
AA723914 pooled MEGF8.a 11004 to 11200 196 to 1       196/196
(100 %)
3 diff
(98.5 %id)
BF941059 dorsal root ganglia MEGF8.a 11062 to 11206 153 to 9       145/153
(94 %)
0 diff
(100 %id)
AY280362   MEGF8.b 1 to 8305 2 to 8307 exact tiling clone,   8307/8307
(100 %)
1 diff
(100.0 %id)
BE261450 brain, neuroblastoma MEGF8.b 875 to 1498 1 to 626       626/702
(89 %)
12 diff
(98.3 %id)
BE260908 brain, neuroblastoma MEGF8.b 876 to 1497 1 to 652       585/852
(68 %)
35 diff
(95.9 %id)
BI063324 uterus_tumor MEGF8.c 1 to 307 1 to 307   tiling clone,   307/307
(100 %)
3 diff
(99.1 %id)
BU850139 ovary, teratocarcinoma, cell line MEGF8.c 73 to 975 1 to 907   tiling clone,   907/912
(99 %)
23 diff
(97.5 %id)
BG114400 Bone, osteosarcoma, cell line MEGF8.c 849 to 1361 1 to 513   tiling clone,   513/553
(92 %)
18 diff
(96.8 %id)
BE467255 carcinoid, lung MEGF8.c 882 to 1418 537 to 1   tiling clone,   537/573
(93 %)
23 diff
(96.0 %id)
BX440695 brain, fetal brain MEGF8.d 1 to 1014 7 to 1015 A2S W3R G4D A34X P273H ... tiling clone,   1009/1018
(99 %)
19 diff
(98.2 %id)
BI193342 epithelioid carcinoma cell line, Pancreas MEGF8.d 329 to 1001 1 to 663   available from MGC,   663/663
(100 %)
15 diff
(97.8 %id)
BC033228 Pancreas, epithelioid carcinoma MEGF8.d 330 to 3004 1 to 2675   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2675/2675
(100 %)
1 diff
(100.0 %id)
CN281630 embryonic stem cells, cell lines H1, H7, andH9 MEGF8.e 1 to 643 16 to 659 G32K Q33P Q34A C35V Y36L ... tiling clone,   644/659
(97 %)
10 diff
(98.5 %id)
BE795651 lung, small cell carcinoma MEGF8.f 1 to 779 1 to 775 C49V R50V G51E N52I S53A ... tiling clone,   775/997
(77 %)
21 diff
(97.9 %id)
BE063101 breast MEGF8.g-u 1 to 341 6 to 346 W7L D8G G9R E10* tiling clone,   341/356
(95 %)
10 diff
(97.2 %id)
AA985483 Kidney, kidney tumor MEGF8.h 1 to 225 224 to 1 A18L P20L A21L Q23N C24A ... tiling clone,   224/224
(100 %)
1 diff
(99.6 %id)
CV383188 prostate_tumor MEGF8.i 1 to 284 38 to 324 W35S A42P V53A S54E D55L ... tiling clone,   287/333
(86 %)
27 diff
(91.9 %id)
DB065337 testis MEGF8.j 1 to 535 2 to 536 exact tiling clone, capped   535/535
(100 %)
0 diff
(100 %id)
BF887618 testis_normal Gene MEGF8, variant not shown         Suspected internal deletion, this clone was ignored    
CF143544 lymph Gene MEGF8, variant not shown         Suspected internal deletion, this clone was ignored    
CD514271 White Matter Gene MEGF8, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154175033   Gene MEGF8, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI